Gamma scintigraphy is a safe non-invasive method for determining the biodistribution of drug delivery systems under physiological conditions, providing critical data early in the clinical development process.The successful application of scintigraphy reliesupon direct or indirect radiolabelling of a selected component of the dosage form using a suitable gamma-emitting radioisotope such as Technetium-99m or Indium-111.
Depending upon the study objectives, protocols may include regional or whole body imaging using planar scintigraphy, or SPECT techniques. Following dosing, the deposition, residence, clearance and dispersion of the dosage form can be defined. The scintigraphic analysis can also be complimented with expertise in pharmacokinetic and pharmacodynamic evaluations, drug assay development and bioanalysis.Imaging is performed using a ‘state of the art’ dual head gamma camera, situated in a purpose-built scintigraphy suite located in a GMP and GCP accredited facility.
Clinical Capabilities
CSL has formally collaborated with Simbec-Orionfor over 25 years to provide a unique single resource for high quality scintigraphy studies in human subjects. The alliance provides support for all aspects of the clinical trial process, including:
Study Design & Protocol Development
Project Management
Regulatory Support
Clinical Monitoring
Pharmacovigilance
Central Laboratory
Bioanalytical Laboratory
IMP Management
Biometrics
Medical & Technical Writing
Scintigraphy
Gamma scintigraphy is a safe non-invasive method for determining the biodistribution of drug delivery systems under physiological conditions, providing critical data early in the clinical development process.The successful application of scintigraphy reliesupon direct or indirect radiolabelling of a selected component of the dosage form using a suitable gamma-emitting radioisotope such as Technetium-99m or Indium-111.
Depending upon the study objectives, protocols may include regional or whole body imaging using planar scintigraphy, or SPECT techniques. Following dosing, the deposition, residence, clearance and dispersion of the dosage form can be defined. The scintigraphic analysis can also be complimented with expertise in pharmacokinetic and pharmacodynamic evaluations, drug assay development and bioanalysis.Imaging is performed using a ‘state of the art’ dual head gamma camera, situated in a purpose-built scintigraphy suite located in a GMP and GCP accredited facility.
Clinical Capabilities
In partnership with Simbec-OrionCSL undertakes all aspects of the clinical trial process, including:
Study Design & Protocol Development
Project Management
Regulatory Support
Clinical Monitoring
Pharmacovigilance
Central Laboratory
Bioanalytical Laboratory
IMP Management
Biometrics
Medical & Technical Writing
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy